Importance Infective endocarditis occurs in approximately 15 of 100 000 people in the
United States and has increased in incidence. Clinicians must make treatment decisions …

Staphylococcus aureus is a major cause of nosocomial and community‐acquired infections
and contributes to significant increase in morbidity and mortality especially when associated …

Background: Rising rates of hospitalization for infective endocarditis (IE) have been
increasingly tied to rising injection drug use (IDU) associated with the opioid epidemic …

Electronic medical claims (EMCs) can be used to accurately predict the occurrence of a
variety of diseases, which can contribute to precise medical interventions. While there is a …

Background Host factors and complications have been associated with higher mortality in
infective endocarditis (IE). We sought to develop and validate a model of clinical …

Background Information on outcomes of methicillin-susceptible and-resistant
Staphylococcus aureus (MSSA and MRSA, respectively) bacteremia, particularly …

Background With increasing prevalence of injected drug use in the United States, a growing
number of intravenous drug users (IVDUs) are at risk for infective endocarditis (IE) that may …

Highlights•Echocardiography remains the initial imaging modality in suspected
endocarditis.•The sensitivity of TTE and TEE for detecting abscesses is 50% and 90 …

Background—Whether oral anticoagulant use should be considered in patients undergoing
hemodialysis with atrial fibrillation (AF) remains controversial because of the uncertainty …

Background Despite advances in medical knowledge, technology and antimicrobial therapy,
infective endocarditis (IE) is still associated with devastating outcomes. No reviews have yet …